Unmet Clinical Need
Addresses hospital-acquired infection (HAI) cross-contamination vectors, device preparation delays, and anatomical tracking resistance by delivering a sterile, single-use high-performance system for Specialty Medical Device procedures.
Recommended Intended Use & Clinical Indication
The Novel Surgical System is indicated for use by healthcare professionals for diagnostic or therapeutic interventions in Specialty Medical Device patient care, according to validated clinical protocols and instructions for use.
Standard medical devices with established clinical mechanisms clear through the Class II 510(k) pathway referencing published substantial equivalence benchmarks.
Related Devices & Reference Product Codes
| Device / Predicate Example | Product Code | Regulation | Class | Pathway |
|---|---|---|---|---|
| Generic Medical Device Predicate A | GEI | 21 CFR 878.4400 | Class II | 510(k) (K201122) |
| Standard Clinical Reference Device B | GEI | 21 CFR 878.4400 | Class II | 510(k) (K182410) |
Opportunity Analyzer Estimate
Custom device opportunity evaluation for Novel Surgical System. Score your technical proof of concept, clinician user desirability, and financial payback period against the 10xAnd Opportunity rubric.
- Technical Feasibility: Medium-High (Feasible based on analogous clearance benchmarks)
- User Desirability: High (Direct clinical demand identified in VOC workflow analysis)
- Financial Viability: High (Favorable unit gross margins and established procedure reimbursement)
Venture Capital & Funding Guidance
Funding Stage: Seed / Series A ($1.5M - $5M)
Typical Check Size: $750k - $2.5M
Investment Thesis: Investors back Specialty Medical Device devices demonstrating clear intellectual property defensibility, strong clinician champion adoption, and capital-efficient clearance milestones.
Grants & Specialty Banks: NIH / NSF SBIR Phase I & II grants ($300k - $2M non-dilutive), specialized MedTech commercial bank credit lines, state bioscience matching grants.
Create Pitch Deck & Find Funding
10xAnd assists engineering founders in developing investor-grade pitch decks, mechanism-of-action (MoA) animations, and photorealistic 3D surgical procedure videos (CFD/FEA simulation renders) that resonate with clinical angel syndicates and life science venture funds.
Private Funding Resources
Angel syndicates (AngelMD, Life Science Angels), MedTech family offices, specialized venture debt (Silicon Valley Bank, Western Technology Investment, Horizon Tech Finance), and non-dilutive foundation grants (Wellcome Trust, AHA Innovation Development Fund).
Project Timeline (Phase by Phase)
FDA Review Duration Baseline (Phase 5 Milestone)
Benchmark review duration under Product Code "GEI"
Review durations under product code GEI provide the empirical baseline for substantial equivalence review.
For an accelerated review strategy or pre-submission engagement, work with 10xAnd regulatory engineers.
Voice of Customer (VOC) clinician interviews to identify workflow pain points, preliminary user needs definition, rapid proof-of-concept bench prototyping, physics/FEA screening, and financial viability/target BOM cost modeling for Novel Surgical System.
Rapid bench testing, ASTM F1980 accelerated 1-year aging (with concurrent real-time protocol to extend shelf-life post-launch), burst pressure, and ISO 11607 sterile barrier integrity.
Simulated-use usability evaluations with intended clinical users in simulated OR/procedure environments.
Compilation of substantial equivalence evidence, bench verification, and sterilization validation.
Transfer to cleanroom assembly line, blister/pouch sealing qualification (IQ/OQ/PQ), and distribution.
Full Project Schedule & Acceleration Breakdown
Standard Industry Waterfall vs 10xAnd Accelerated Concurrent Engineering
Basis: a modelled planning schedule, not observed performance. It charts the same phases and the same durations as the roadmap above — the standard track runs them end to end with no overlap. The 10xAnd track applies the per-phase tooling shown against each row and starts each phase partway through the one before it (concurrent engineering). FDA review time is barely reduced, because that clock is the agency's; the lever there is a dossier that draws fewer deficiency cycles. Every duration is a range, and the hatched part of each bar is its longer run. Months are design targets for planning, not measured outcomes, and no schedule here is a commitment.
Project Cost Breakdown (Estimated Budget Ranges)
| Project Development Phase / Expense | Estimated Low (USD) | Estimated High (USD) | Scope & Benchmarks |
|---|---|---|---|
| Phase 0 VOC, Ergonomics & Bench Prototyping | $45,000 | $95,000 | Clinician interviews, ergonomic models, rapid 3D prototyping, target COGS targets |
| CAD Modeling, Mold Tooling & Pilot Production | $120,000 | $280,000 | Injection mold tooling, extrusion dies, assembly fixtures |
| Bench V&V & Packaging Integrity (1-Yr Shelf Life) | $90,000 | $220,000 | ASTM F1980 accelerated aging, dye penetration, seal peel strength, simulated shipping |
| ISO 10993 Biocompatibility Testing | $65,000 | $160,000 | Cytotoxicity, sensitization, irritation, and systemic toxicity for mucosal/tissue contact |
| Clinician Usability & Design Validation Study | $30,000 | $65,000 | Summative human factors testing with 15 representative clinical users |
| FDA MDUFA 510(k) User Fee (Small Business vs Standard) | $5,543 | $22,170 | FDA 510(k) review fee |
| Regulatory Consulting & eSTAR 510(k) Authoring | $35,000 | $85,000 | Substantial equivalence comparison, test summaries, and FDA eSTAR formatting |
| Total Estimated Development Budget | $390,543 | $927,170 | Total projected investment through initial clearance & commercial transfer |
Design & Development Tools
- SolidWorks / PTC Creo CAD CAD Modeling
3D parametric geometry, housing design, and tolerance analysis
- Ansys Mechanical / Abaqus FEA Structural Simulation
Structural stress analysis, fatigue life, and material optimization
- COMSOL / Ansys Fluent CFD Fluid Simulation
Thermal dissipation and fluid dynamics evaluation
Related Medical Components & Suggested Vendors
- Medical-Grade Polymers & Tubing Component Atlas ↗
USP Class VI / ISO 10993 certified biocompatible extrusions · ISO 10993 / USP Class VI
Suggested Vendors: Zeus, Teleflex Medical OEM, Nordson Medical
- Precision Machined / Laser Cut Metal Alloys Component Atlas ↗
Titanium, nitinol, and surgical stainless steel micro-components · ASTM F136 / ASTM F899
Suggested Vendors: Resonetics, MeKo Laser, Heraeus Medical Components
- Sterile Barrier Packaging Component Atlas ↗
Dual Tyvek peel pouches and rigid PETG thermoformed trays · ISO 11607-1 / ASTM F1980
Suggested Vendors: Oliver Healthcare Packaging, Amcor Healthcare
Drafting, Simulation, FEA & CFD
Our team provides specialized biomedical engineering simulation and design controls documentation to de-risk development prior to cutting metal or clinical trials.
Finite Element Analysis (FEA) & Stress Simulation
Predictive structural modeling under peak clinical load cases to optimize wall thickness and verify safety factors before cutting tooling.
Deliverable: Comprehensive FEA Structural Verification Report
Full CAD 2D/3D Production Drawing Package
Detailed parametric models, assembly drawings, and DFM tolerance stacks compliant with ASME Y14.5M GD&T standards.
Deliverable: Complete DFM Manufacturing Drawing Package
Design Controls & Usability Protocol Authoring
Compiling Design History File (DHF) deliverables, User Needs Traceability, and IEC 62366-1 human factors protocols.
Deliverable: Audit-ready DHF Package and Simulated-Use Test Protocol
Governing FDA Recognized Consensus Standards & Applicability
Cross-reference horizontal safety standards (ISO 10993, IEC 60601, ISO 14971) and vertical product standards governing this device classification.
Design Verification (V&V) Testing Suite
| Test Discipline | Standard | Objective |
|---|---|---|
| Mechanical Proof Load & Functional Durability | ASTM Standards | Verify device integrity under simulated worst-case clinical loads |
| ISO 10993 Biocompatibility Testing Suite | ISO 10993-1 | Verify biological safety based on patient contact nature and duration |
| Sterile Barrier & Packaging Integrity | ISO 11607 / ASTM F1980 | Validate sterility maintenance across defined shelf life |
ISO 10993 Biocompatibility Evaluation
- Cytotoxicity & Sensitization (ISO 10993-5 / ISO 10993-10)
ISO L929 MEM elution and closed-patch sensitization on sterile finished goods.
- Irritation & Intracutaneous Toxicity (ISO 10993-23 / ISO 10993-11)
Polar and non-polar extract testing for acute tissue reactivity and systemic response.
- Hemocompatibility (Transient Contact) (ISO 10993-4)
ASTM F756 in vitro hemolytic index and partial thromboplastin time (PTT) assays.
- Material-Mediated Pyrogenicity (ISO 10993-11 Annex G)
Rabbit pyrogen test or validated Monocyte Activation Test (MAT) detecting non-endotoxin pyrogens.
Biocompatibility Risk & Chemical Characterization
Assure testing endpoints and ISO 10993-18 extractables/leachables matrices match clinical tissue contact duration and device materials.
Sterilization & Shelf-Life Validation
Method: Ethylene Oxide (EtO)
Standard: ISO 11135
Alternative: Gamma Radiation (Cobalt-60) or E-Beam
Standard: ISO 11137-1 / ISO 11137-2
Material Compatibility Rationale: EtO prevents thermal warping of thin-walled polymer shafts and hydrophilic lubricious coatings. Radiation (25 kGy VDmax) is a rapid alternative provided all resin formulations are radiation-stabilized to avoid yellowing.
Validation Protocol: Half-cycle overkill method (10â»â¶ SAL) with 1-year ASTM F1980 accelerated aging protocol
Sterile Packaging: ISO 11607 Tyvek header pouches and thermoformed PETG trays
Validating for Clinical Users
While Design Verification proves engineering specifications ("did you design the device right?"), Design Validation proves the device satisfies user needs and intended clinical uses ("did you design the right device?").
Clinical Focus: Validating clinical user workflow, ergonomics, and error-free operation of Novel Surgical System with representative clinicians.
Human Factors Standard: IEC 62366-1
Study Structure: Summative usability evaluation with 15 representative clinical users in simulated clinical environment.
10xAnd custom-builds anatomical silicone phantoms and 3D-printed pulsatile/tortuous flow models matching patient CT geometries to validate device handling, tracking force, and clinical deployment under fluoroscopy/endoscopy.
Access to accredited surgical training facilities and tissue banks for human and porcine cadaveric evaluations, facilitating realistic procedural simulations and clinician ergonomic feedback under IRB/IACUC protocols.
10xAnd Design Validation Protocols & Study Facilitation
10xAnd designs the clinical test phantoms, drafts the human factors study protocol, coordinates cadaveric sessions, and compiles the design validation summary report.
Service Atlas: Accredited Testing Laboratories
Microbiology, ISO 11135 / 11137 sterilization validation, bioburden, packaging integrity
Visit Nelson Laboratories ↗ISO 10993 full biocompatibility panel, GLP preclinical animal safety studies, IVD trials
Visit NAMSA ↗Package transit testing (ASTM D4169), extractables & leachables, chemical characterization
Visit Eurofins Medical Device Testing ↗USA Regulatory Submission Creation
Submission Type: 510(k) — 21 CFR 878.4400
Submission Format: FDA eSTAR 510(k)
Pre-Submission (Q-Sub) Recommended: Recommended
Strategy: Prepare traditional 510(k) substantial equivalence comparison against reference predicate under product code GEI.
Reference Tool: 10xAnd Regulatory Submission Tool (automated eSTAR compiler & pre-submission tracker)
10xAnd compiles test summaries, formats the eSTAR XML dossier, and manages FDA reviewer inquiries.
Curated Notified Bodies (Top 2 for Project)
Under EU MDR 2017/745, technical documentation and QMS certification are audited by a designated Notified Body. We recommend BSI Group (NB 2797) or TÃœV SÃœD (NB 0123) based on scope expertise.
| Notified Body | Identification | Designated Scope | Link |
|---|---|---|---|
| BSI Group (United Kingdom / Netherlands) | NB 0086 / NB 2797 | Full scope EU MDR & IVDR, active implants, cardiovascular, orthopedics, software, drug-device combos | Visit ↗ |
| TÃœV SÃœD Product Service (Germany) | NB 0123 | High-risk cardiovascular, orthopedics, IVDs, functional safety, electro-medical systems | Visit ↗ |
How 10xAnd Assists with Notified Bodies
10xAnd prepares EU MDR Technical Documentation (Annex II/III), Clinical Evaluation Reports (CER), and prepares engineering teams for Notified Body QMS audits.
Contract Manufacturing Services
Cleanroom Environment: ISO Class 7 or Class 8 cleanroom
Quality Management Standard: ISO 13485:2016 and FDA 21 CFR Part 820 certified
Selection Criteria: Experience with analogous medical devices, validated cleaning lines, and lot-level traceability.
Candidate Contract Manufacturers:
10xAnd Contract Manufacturing Assessment & Alignment
10xAnd has established relationships and vetting frameworks with medical contract manufacturers to evaluate cleanroom capacity, assembly automation, and IQ/OQ/PQ master validation.
Manufacturing Equipment & Pilot Line Setup
Transferring from bench prototyping to scalable manufacturing requires robust equipment selection and validated processes under 21 CFR 820.75.
- Equipment Sourcing & Specification:
Drafting User Requirement Specifications (URS) and Functional Requirement Specifications (FRS) for automated assembly fixtures, laser cutters, and ultrasonic welders.
- Process Validation Master Protocols (IQ/OQ/PQ):
Authoring Installation Qualification (IQ), Operational Qualification (OQ challenging high/low parameter edges), and Performance Qualification (PQ 3-lot reproducibility).
- Design for Manufacturability (DFM) Reviews:
Optimizing draft angles, wall thicknesses, and modular sub-assemblies to lower unit scrap rates and scale cleanroom throughput.
Market Access & Reimbursement Strategy
Payment & Coverage Pathway: CPT Procedure Coding or Hospital DRG Inpatient Payment
Applicable Coding Framework: Established category-specific CPT / HCPCS / DRG coding frameworks
Hospital Value Analysis Dossier: Hospital Value Analysis Committee (VAC) dossier highlighting clinical efficacy, time savings, and cost-effectiveness for Novel Surgical System.
Commercial Distribution Channel: Direct medical sales specialists, specialized distributor networks, and hospital group purchasing organizations (GPOs).
Reference Tool: 10xAnd CPT, HCPCS & DRG Reimbursement Landscape Evaluation Tool
Helps medtech sponsors evaluate key stakeholders, determine CPT/HCPCS/DRG coding crosswalks, and build payer coverage dossiers.
Commercial Launch Acceleration
10xAnd creates 3D photorealistic mechanism-of-action animations, surgeon procedural guides, and clinical marketing collateral.
- Photorealistic 3D Medical Animations:
Dynamic mechanism-of-action (MoA) animations communicating anatomical benefits to surgeons, investors, and hospital procurement committees.
- Surgical Technique Manuals & IFUs:
Clean, step-by-step procedural guides and quick reference cards compliant with FDA labeling and ISO 20417.
- Post-Market Surveillance (PMS) Setup:
Establishing customer complaint handling feedback loops, vigilance reporting, and Post-Market Clinical Follow-up (PMCF) plans.